PPT-Antiretroviral Agents: HIV & AIDS

Shaw Vonder Hoya Worldwide Prevalence Types of HIV HIV type 1 Most common Originated from chimpanzee SIV High infectivity and virulence HIV type 2 Mostly confined to West Africa Came from sooty . Directed Readings . In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Culture. By: Julie R. & Haley B.. Religion. The main religion that is dominant with Aids is . Islamic. . The main religion in Africa is . Islamic, . which many cases are found in that country. . Ethnicity and Religion Continued. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). Kiat. . Ruxrungtham. Professor of Medicine, . Chulalongkorn University; and. HIV-NAT, Thai Red Cross AIDS Research Center. Three Decades of HIV/AIDS . Learning and the Future. Mid 1990. 1981. 2012 - 2014. In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Barnaby Young. Infectious Diseases registrar. Communicable Diseases Centre,. Institute of Infectious Diseases and . Epidemiology,. Tan Tock . Seng. Hospital, Singapore. Overview. F. inancing of public healthcare in Singapore – and how HIV funding changed in early 2010. Lessons from the Emergency . Plan. Dr. Nadia A. Sam-Agudu. Senior Technical Advisor, Pediatric and Adolescent HIV. Institute of Human Virology Nigeria, . Abuja.. Assistant . Professor of Pediatrics, . Duke University Medical Center. Durham, North Carolina. New Guidelines, Strategies, and Drugs for Initiation of Antiretroviral Therapy 2013. From CB Hicks, MD, at Chicago, IL: May 20, 2013, IAS-USA.. Willard . Tinago. , . PhD. HIV . Molecular Research Group. UCD School of Medicine. UCD School of Medicine . 3.3 By . 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable . Kiat. . Ruxrungtham. Professor of Medicine, . Chulalongkorn University; and. HIV-NAT, Thai Red Cross AIDS Research Center. Three Decades of HIV/AIDS . Learning and the Future. Mid 1990. 1981. 2012 - 2014. With Protocol for. Rapid Initiation. . www.hivguidelines.org. Purpose of This Guideline. Provides guidance for choosing safe and efficacious ART regimens based on known patient characteristics, before results of recommended resistance testing or baseline laboratory testing are available.. PS2008_006 V2014 1 t el: +31 70 3060 520 www.internationalmidwives.org Position Statement Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome (HIV and AIDS) Background The human immun Bob Harrington, MD. University of Washington . Presentation prepared by: . Presenter. Last Updated: . Date. Early Vs Deferred HAART . Strategic Timing of . AntiRetroviral. Treatment (START) Study. START: 2015. Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection.